Clinical Trials Logo
  1. Home
  2. Pulmonary Thromboembolism
  3. NCT04405869
  4. Details
NCT04405869 Clinical Trial

Thromboembolic Events in Severe COVID-19 Patients

Pulmonary Thromboembolism Clinical Trial

— COVICLOT  

Official title:
Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04405869
Other study ID # 7779
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 29, 2020
Est. completion date April 2021

Study information
Verified date May 2020
Source University Hospital, Strasbourg, France
Contact Charles TACQUARD, MD
Phone 33 3 69 55 16 08
Email charlesambroise.tacquard@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events

Recruitment information / eligibility
Status Recruiting
Enrollment 300
Est. completion date April 2021
Est. primary completion date April 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Confirmed infection with the Sars-CoV-2 virus (RT-PCR)

- Hospitalization in Intensive Care Unit

- Age over 18 years Old

Exclusion Criteria:

- Refusal of the patient to participate in data collection

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil Strasbourg

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Analysis of incidence of thromboembolic events in patients with Sars-CoV-2 1 month
See also
  Status Clinical Trial Phase
Completed NCT01580085 - Obstructive Sleep Apnea in Pulmonary Embolism N/A
Enrolling by invitation NCT01558206 - Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE N/A
Completed NCT01513759 - Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy Phase 3
Completed NCT02616991 - Computed Tomography CT Venography During Postpartum Venous Thromboembolism N/A
Completed NCT00968929 - Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) Phase 4
Not yet recruiting NCT06206967 - Promotion of Active Lifestyle in Thromboembolism Patients N/A
Completed NCT03595891 - The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung
Completed NCT01206751 - Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation N/A